case study

FDA 510(k)

A suitable cleaning and disinfection process needed to be validated as safe and effective, and a regulatory analysis was needed to determine the need for any regulatory submissions.

About RCA
Regulatory Compliance Associates® Inc. (RCA) provides worldwide services to the pharmaceutical, biologic, sterile compounding, biotechnology, and medical device industries for resolution of compliance and regulatory challenges.

Please complete the form to access the case study.

*=Required

FDA 510(k)

Background

A Fortune 500 company needed medical device consultants to perform a FDA 510k analysis for a family of medical devices. The goal of eliminating pre-sterilization by ethylene oxide (EtO) was intended to replace providing instructions for cleaning to the customer and disinfecting the product prior to use. Disinfecting was critical in the event that the customer may choose to reuse the product.

The elimination of EtO sterilization would result in a substantial reduction in the cost of manufacturing. Eliminating the cost of the sterilization and use of lower-cost packaging materials could save the client millions of dollars annually.

Challenge

A suitable cleaning and disinfection process needed to be validated as safe and effective, and a regulatory analysis was needed to determine the need for any 510k regulatory submissions.

Approach

Regulatory Compliance Associates® developed a test plan and coordinated testing that demonstrated a microbiological log reduction of greater than 103 using the proposed cleaning and disinfection process. Additionally, a formal regulatory analysis was conducted, evaluating the nature of the product application and relevant predicate medical device 510(k) filings to determine the necessity for filing a 510(k).

Results

The regulatory analysis concluded that a 510(k) filing to clear the change with FDA was not required. Instead, a formal regulatory opinion and supporting validation testing was documented in the product Design History File.

Due to not needing the 510(k), the project was completed under budget by over 60 percent, and the client realized a substantial product cost savings several months ahead of schedule.

 

To begin the Regulatory Compliance Associates® scoping process today, please enter your information in the blue form below and click the submit button at the bottom of the webpage. 

 

References

  1. U.S. Department of Health and Human Services, Food and Drug Administration, “Deciding When to Submit a 510(k) for a Change to an Existing Device, (K97-1)” January 10, 1997.
  2. International Standards Organization, ISO Standard 17664: Sterilization of Medical Devices—Information to be provided by the manufacturer for processing of resterilizable medical devices. 2004.
  3. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, “Guidance for Industry and FDA Staff: Medical Device User Fee and Modernization Act of 2002, Validation Data in Premarket Notification Submissions (510(k)s) for Reprocessed Single-Use Medical Devices,” September 25, 2006.

Background

A Fortune 500 company needed medical device consultants to perform a FDA 510k analysis for a family of medical devices. The goal of eliminating pre-sterilization by ethylene oxide (EtO) was intended to replace providing instructions for cleaning to the customer and disinfecting the product prior to use. Disinfecting was critical in the event that the customer may choose to reuse the product.

The elimination of EtO sterilization would result in a substantial reduction in the cost of manufacturing. Eliminating the cost of the sterilization and use of lower-cost packaging materials could save the client millions of dollars annually.

Challenge

A suitable cleaning and disinfection process needed to be validated as safe and effective, and a regulatory analysis was needed to determine the need for any 510k regulatory submissions.

Approach

Regulatory Compliance Associates® developed a test plan and coordinated testing that demonstrated a microbiological log reduction of greater than 103 using the proposed cleaning and disinfection process. Additionally, a formal regulatory analysis was conducted, evaluating the nature of the product application and relevant predicate medical device 510(k) filings to determine the necessity for filing a 510(k).

Results

The regulatory analysis concluded that a 510(k) filing to clear the change with FDA was not required. Instead, a formal regulatory opinion and supporting validation testing was documented in the product Design History File.

Due to not needing the 510(k), the project was completed under budget by over 60 percent, and the client realized a substantial product cost savings several months ahead of schedule.

 

To begin the Regulatory Compliance Associates® scoping process today, please enter your information in the blue form below and click the submit button at the bottom of the webpage.